NEWS
Center for Houston’s Future Webcast: Building Public Trust in Communications about COVID-19

This webcast, presented by Center for Houston’s Future and Leadership Now, focuses on ways to build public trust in communicating about the pandemic and what strategies policymakers and health officials can use to provide fact-based, simple communications to the public about COVID-19. Panelists: Dr. Asaf Bitton, Ariadne Labs Dr. Emily Brunson, Texas State University Christy… Continue reading Center for Houston’s Future Webcast: Building Public Trust in Communications about COVID-19

Sep 3 2020
NEWS - Perspectives
The New Yorker: We Can Solve the Coronavirus-Test Mess Now—If We Want To

Dr. Atul Gawande on “assurance testing” and a new vision of what public health really means.

Sep 2 2020
NEWS - Perspectives
New York Times: More Than 70,000 Covid-19 Patients Have Received Plasma. Does It Help?

Dr. Daniela Lamas discusses the need for evidence-based treatments, and the risk of haste.

NEWS
HuffPost: The Vaccine Race Has Become A High-Stakes Geopolitical Gamble

Dr. Rebecca Weintraub on the need for global COVID-19 vaccine initiative.

Sep 1 2020
NEWS - Perspectives
Health Affairs: Promoting Innovation and Equity as COVID-19 Vaccines And Treatment Emerge

Dr. Rebecca Weintraub presents on COVID-19 vaccine access at a Health Affairs virtual symposium (begins at 2:22:30).

Aug 26 2020
Medicaid and Quality of Care: How our Funding Structure Failed Nursing Homes

By Sam Cox COVID-19 has upended all areas of society, but among the populations worst affected are elderly residents of long-term care facilities. Older adults are most vulnerable to serious complications of COVID-19, representing over 80% of COVID-19 deaths in the United States despite making up just 15.6% of the population. Older adults living in… Continue reading Medicaid and Quality of Care: How our Funding Structure Failed Nursing Homes

Modelling the Manufacturing Process for COVID-19 Vaccines: Our Approach

The Center for Global Development and Ariadne Labs have teamed up to better understand how long it will take to develop a COVID-19 vaccine and manufacture it at scale.

NEWS - Perspectives
Harvard Business Review: Why Businesses Must Help Build Trust in a Covid-19 Vaccine

Dr. Rebecca Weintraub and Julie Rosenberg call on companies to support information campaigns promoting vaccines.

Aug 20 2020